SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

CyberArk, not SentinelOne, was always the goal, says Palo Alto CEO

Palo Alto CEO on $25B CyberArk deal: “This is the lowest our stock will be for the next five years”

CyberArk’s $25B exit enriches global funds, not Israelis

Check Point not for sale, says CEO as Palo Alto buys CyberArk for $25B

Buzz

Most popular

Daily

Weekly

1

Palo Alto closing on over $20 billion acquisition of CyberArk

2

Wiz finds major security flaw in Base44, one month after Wix acquisition

3

Palo Alto to acquire CyberArk for $25B in landmark cybersecurity deal

4

Intel’s global overhaul: What the memo didn’t say

5

Intel veterans raise $40 million to scale AI surveillance platform

Fosun Pharma

8 stories about Fosun Pharma

גיל נאור יזם מיטראסיסט

Israel's Mitrassist Medical raises $50 million for medical valve development

02.12.20|Meir Orbach

China's Fosun Pharma, insurance company Ping-An and four large Chinese funds all took part in the round

הזרקת חומר להמסת שומן בסנטר

Double-chin reducing Israeli startup closes $74 million China licensing deal

22.09.20|Meir Orbach

The agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound

מימין קאלואן פוסון ויליאם הו פוסום ליאור דיין מיסטר לואי

Fosun Whetted Our Appetite, Says Alma Lasers CEO

04.07.19|Golan Hazani

Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013

קיסריה קמפוס גרניט 2

Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea

10.12.18|Dotan Levy

The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers

בורסת הונג קונג בורסה בורסות אסיה

Fosun Pharma Acquires Israeli Distributer Via Israeli Subsidiary Sisram

28.11.18|Golan Hazani

Sisram Medical, formerly Alma Lasers, is buying Nova Medical, one of the largest distributors of medical aesthetic devices in Israel

גואו גואנצ'אנג יו"ר קבוצת פוסון

Fosun Leads $30 Million Round for Heart Valve Company MitrAssist

08.11.17|Lilach Baumer

The Israel-based company develops a valve implant that can be installed through thigh catheterization instead of invasive heart surgery

בורסת הונג קונג בורסה בורסות אסיה

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert

The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday

בורסת הונג קונג בורסה בורסות אסיה

Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO

10.09.17|Amarelle Wenkert

On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange